General Information of Drug (ID: DR5490)
Drug Name
Docarpamine
Synonyms Tanadopa (TN)
Indication Hypertension [ICD11: BA00-BA04] Approved [1]
Structure
3D MOL 2D MOL
Pharmaceutical Properties Molecular Weight 470.5 Topological Polar Surface Area 155
Heavy Atom Count 32 Rotatable Bond Count 16
Hydrogen Bond Donor Count 2 Hydrogen Bond Acceptor Count 9
Cross-matching ID
PubChem CID
71137
ChEBI ID
CHEBI:31513
CAS Number
74639-40-0
TTD Drug ID
D0K2TB
Formula
C21H30N2O8S
Canonical SMILES
CCOC(=O)OC1=C(C=C(C=C1)CCNC(=O)[C@H](CCSC)NC(=O)C)OC(=O)OCC
InChI
InChI=1S/C21H30N2O8S/c1-5-28-20(26)30-17-8-7-15(13-18(17)31-21(27)29-6-2)9-11-22-19(25)16(10-12-32-4)23-14(3)24/h7-8,13,16H,5-6,9-12H2,1-4H3,(H,22,25)(H,23,24)/t16-/m0/s1
InChIKey
ZLVMAMIPILWYHQ-INIZCTEOSA-N
The Metabolic Roadmap of This Drug
The Full List of Drug Metabolites (DM) of This Drug
DM Name DM ID PubChem ID Reaction DM Level REF
DEC-TA-870 DM015393
3035510
Unclear - Unclear 1 [2]
Dopamine DM000276
681
Unclear - Unclear 2 [2]
(3,4-Dihydroxyphenyl)acetic acid DM000280
547
Unclear - Unclear 3 [2]
3-MT DM000277
1669
Unclear - Unclear 3 [2]
3'-Hydroxyphenylacetic acid DM004109
12122
Unclear - Unclear 4 [2]
HVA DM003106
1738
Unclear - Unclear 4 [2]
The Full List of Metabolic Reaction (MR) of This Drug
MR ID Reactant Product MR Type DME REF
MR008911 Docarpamine DEC-TA-870 Unclear - Unclear Unclear [2]
MR008912 DEC-TA-870 Dopamine Unclear - Unclear Unclear [2]
MR008913 Dopamine 3-methoxytyramine Unclear - Unclear COMT [2]
MR008915 Dopamine 3,4-dihydroxyphenylacetic acid Unclear - Unclear MAO [2]
MR008916 3,4-dihydroxyphenylacetic acid 3-hydroxyphenylacetic acid Unclear - Unclear Unclear [2]
MR008914 3-methoxytyramine Homovanillic acid Unclear - Unclear Unclear [2]
⏷ Show the Full List of 6 MR(s)
Drug-Metabolizing Enzyme(s) (DME) Metabolizing This Drug
DME Name DME Info Species Uniprot ID EC Number REF
Catechol O-methyltransferase (COMT) DME0043 Homo sapiens
COMT_HUMAN
2.1.1.6
[2]
Monoamine oxidase (MAO) DMEN059 . Not Available Not Available [2]
References
1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
2 Metabolism of a new orally active dopamine prodrug, N-(N-acetyl-L-methionyl)-O,O-bis(ethoxycarbonyl)dopamine (TA-870) and dopamine after oral administration to rats and dogs

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.